Rescheduling Cannabis—Medicine or Politics?
The HHS rationale for reclassifying cannabis in myriad forms (edibles, smokables, drinkables, vaping products, suppositories) and potencies relies on a questionable selection of comparator drugs, downplays distinctive adverse events among cannabis users, and claims, unconvincingly, that cannabis has wide acceptance in medical practice supported by scientific evidence.
Authors
- Paul J. Larkin
- Bertha K. Madras (ORCID: https://orcid.org/0000-0001-5971-2238)
Institutions
- Heritage Foundation (US)
- Harvard University (US)
- McLean Hospital (US)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1001/jamapsychiatry.2025.1116
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00